About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Upf2tm1Btp
targeted mutation 1, Bo Torben Porse
MGI:3790198
Summary 5 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cn1
Upf2tm1Btp/Upf2tm1Btp
En1tm2(cre)Wrst/En1+
involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ MGI:6718865
cn2
Upf2tm1Btp/Upf2tm1Btp
Tg(Mx1-cre)1Cgn/0
involves: 129P2/OlaHsd * C57BL/6 * CBA MGI:3797491
cn3
Tg(Lck-cre)548Jxm/?
Upf2tm1Btp/Upf2tm1Btp
involves: 129P2/OlaHsd * C57BL/6 * CBA MGI:3797492
cn4
Upf2tm1Btp/Upf2tm1Btp
Lyz2tm1(cre)Ifo/?
involves: 129P2/OlaHsd * C57BL/6 * CBA MGI:3797493
cn5
Upf2tm1Btp/Upf2tm1Btp
Tg(Atoh1-cre)1Bfri/0
involves: 129P2/OlaHsd * C57BL/6 * CBA MGI:6718866


Genotype
MGI:6718865
cn1
Allelic
Composition
Upf2tm1Btp/Upf2tm1Btp
En1tm2(cre)Wrst/En1+
Genetic
Background
involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
En1tm2(cre)Wrst mutation (1 available); any En1 mutation (34 available)
Upf2tm1Btp mutation (0 available); any Upf2 mutation (63 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
nervous system
• increased apoptotic cells in the cerebellum in both the ventricular zone and the prospective white matter
• in the ventricular zone progenitors at E13.5
• grossly hypoplastic being nearly absent
• grossly hypoplastic being nearly absent
• grossly being nearly absent
• at E13.5 in the cerebellum

cellular
• increased apoptotic cells in the cerebellum in both the ventricular zone and the prospective white matter
• in the ventricular zone progenitors at E13.5




Genotype
MGI:3797491
cn2
Allelic
Composition
Upf2tm1Btp/Upf2tm1Btp
Tg(Mx1-cre)1Cgn/0
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(Mx1-cre)1Cgn mutation (7 available)
Upf2tm1Btp mutation (0 available); any Upf2 mutation (63 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• induction of Cre by pI-pC administration leads to death within 10 days with a median survival time of 6 days after first injection of pI-pC
• lethally irradiated wild-type mice that receive mutant bone marrow die within 11 days of Cre induction in the bone marrow derived cells

hematopoietic system
• there is a profound reduction in the ability of CD4 and CD8 T cells to proliferate in response to mitogenic stimuli 6 days after induction of Cre by pI-pC administration
• anemia results within 6 days after induction of Cre by pI-pC administration
• there is almost a complete absence of nucleated cells in the bone marrow including stem and progenitor cells 6 days after induction of Cre by pI-pC administration
• there is almost a complete absence of granulocytes in the bone marrow 6 days after induction of Cre by pI-pC administration
• mean RBC counts are reduced by more than half 6 days after induction of Cre by pI-pC administration
• percentage of hematocrit is reduced by more than half 6 days after induction of Cre by pI-pC administration
• hemoglobulin content is reduced by more than half 6 days after induction of Cre by pI-pC administration
• there is almost a complete absence of granulocytes in the bone marrow 6 days after induction of Cre by pI-pC administration
• there is almost a complete absence of B-cells in the bone marrow 6 days after induction of Cre by pI-pC administration
• there is almost a complete absence of hematopoietic progenitors in the bone marrow 6 days after induction of Cre by pI-pC administration

immune system
• there is a profound reduction in the ability of CD4 and CD8 T cells to proliferate in response to mitogenic stimuli 6 days after induction of Cre by pI-pC administration
• there is almost a complete absence of granulocytes in the bone marrow 6 days after induction of Cre by pI-pC administration
• there is almost a complete absence of B-cells in the bone marrow 6 days after induction of Cre by pI-pC administration

cellular
• there is a profound reduction in the ability of CD4 and CD8 T cells to proliferate in response to mitogenic stimuli 6 days after induction of Cre by pI-pC administration




Genotype
MGI:3797492
cn3
Allelic
Composition
Tg(Lck-cre)548Jxm/?
Upf2tm1Btp/Upf2tm1Btp
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(Lck-cre)548Jxm mutation (2 available)
Upf2tm1Btp mutation (0 available); any Upf2 mutation (63 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• significant reduction in size of the thymus with cellularity decreased almost 3-fold
• the percentage of apoptotic cells in the thymus is doubled
• unproductive transcripts with premature stop codons is detectable in 29% of single positive T cells
• there is a 3-fold reduction in the number of double positive T cells found in the thymus
• there is a 4- to 5-fold reduction in CD4 T cells found in the thymus
• the number of CD4 T cells found in the periphery is 30% that of wild-type
• there is a 2-fold to 3-fold reduction in T cell numbers
• the number of CD8 T cells found in the periphery is 30% that of wild-type

hematopoietic system
• significant reduction in size of the thymus with cellularity decreased almost 3-fold
• the percentage of apoptotic cells in the thymus is doubled
• unproductive transcripts with premature stop codons is detectable in 29% of single positive T cells
• there is a 3-fold reduction in the number of double positive T cells found in the thymus
• there is a 4- to 5-fold reduction in CD4 T cells found in the thymus
• the number of CD4 T cells found in the periphery is 30% that of wild-type
• there is a 2-fold to 3-fold reduction in T cell numbers
• the number of CD8 T cells found in the periphery is 30% that of wild-type

endocrine/exocrine glands
• significant reduction in size of the thymus with cellularity decreased almost 3-fold
• the percentage of apoptotic cells in the thymus is doubled




Genotype
MGI:3797493
cn4
Allelic
Composition
Upf2tm1Btp/Upf2tm1Btp
Lyz2tm1(cre)Ifo/?
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Lyz2tm1(cre)Ifo mutation (14 available); any Lyz2 mutation (40 available)
Upf2tm1Btp mutation (0 available); any Upf2 mutation (63 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
N
• no abnormalities are observed in cells of the myeloid lineage




Genotype
MGI:6718866
cn5
Allelic
Composition
Upf2tm1Btp/Upf2tm1Btp
Tg(Atoh1-cre)1Bfri/0
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(Atoh1-cre)1Bfri mutation (1 available)
Upf2tm1Btp mutation (0 available); any Upf2 mutation (63 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
nervous system
• reduced fraction of granule cell precursors exiting the cell cycle in the anterior lobes of the cerebellum
• no clear separation of the inner and outer external granule cell layer
• at P6 in the inner granule layer
• reduced length with failure of Purkinje cells to form a monolayer
• however, the posterior lobes are normal

cellular
• reduced fraction of granule cell precursors exiting the cell cycle in the anterior lobes of the cerebellum





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory